Funding news
Goldenrod Therapeutics logo

Goldenrod Therapeutics Raises $6.5M Seed

Recently funded · $6.5M SeedHospitals and Health CareUSView source

Get the full Goldenrod Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A fresh $6.5M seed round is set to propel Goldenrod Therapeutics' mission to tackle serious neurological conditions with a new class of medicine. The biotech startup, which is developing treatments for ailments including Friedreich's ataxia and other neurodegenerative diseases, announced the funding from investors Ataxia Ventures and Fannin Partners.

Goldenrod's approach refines an established biological pathway in the brain, aiming to overcome the side effects that hampered earlier treatments. By achieving meaningful drug exposure in the brain while maintaining a favorable safety profile, the company hopes to open the door to new options for millions of patients currently with few or no good choices.

From the source

Fannin · Jun 4, 2026

Congratulations to Goldenrod Therapeutics on the initial close of its $6.5 million Series Seed financing, led by Ataxia Ventures and an affiliate of Fannin Partners.

The financing will support advancement of Goldenrod's lead program, 11h, a next-generation, orally bioavailable, brain-penetrant PDE4 inhibitor being developed for Friedreich's Ataxia and other neurodegenerative and neuroinflammatory disorders. Proceeds will fund IND-enabling studies and preparation for a Phase I clinical trial. We're proud to see the continued progress of the Goldenrod team and

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Seed rounds

Companies that recently closed a Seed round.

#CompanyAmount
1
HAGA.BIO logo

HAGA.BIO

Sweden

$2.3M
2
Hexigone Inhibitors logo

Hexigone Inhibitors

United Kingdom

$1.5M
3
Edify Systems logo

Edify Systems

United Kingdom

$4.0M
4
ELLIPSE Bikes logo

ELLIPSE Bikes

France

$1.6M
5
MySunbed logo

MySunbed

France

$1.7M